Safe and effective delivery of supplemental iron to healthy older adults: The double-blind, randomized, placebo-controlled trial protocol of the Safe Iron Study

Erin D Lewis, Dayong Wu, Joel B Mason, Athar H Chishti, John M Leong, Kathryn Barger, Simin N Meydani, Gerald F Combs, Erin D Lewis, Dayong Wu, Joel B Mason, Athar H Chishti, John M Leong, Kathryn Barger, Simin N Meydani, Gerald F Combs

Abstract

The forms of iron currently available to correct iron deficiency have adverse effects, including infectious diarrhea, increased susceptibility to malaria, inflammation and detrimental changes to the gut microbiome. These adverse effects limit their use such that the growing burden of iron deficiency has not abated in recent decades. Here, we summarize the protocol of the "Safe Iron Study", the first clinical study examining the safety and efficacy of novel forms of iron in healthy, iron-replete adults. The Safe Iron Study is a double-blind, randomized, placebo-controlled trial conducted in Boston, MA, USA. This study compares ferrous sulfate heptahydrate (FeSO 4·H 2O) with two novel forms of iron supplements (iron hydroxide adipate tartrate (IHAT) and organic fungal iron metabolite (Aspiron™ Natural Koji Iron)). In Phase I, we will compare each source of iron administrated at a low dose (60 mg Fe/day). We will also determine the effect of FeSO 4 co-administrated with a multiple micronutrient powder and weekly administration of FeSO 4. The forms of iron found to produce no adverse effects, or adverse effects no greater than FeSO 4 in Phase I, Phase II will evaluate a higher, i.e., a therapeutic dose (120 mg Fe/day). The primary outcomes of this study include ex vivo malaria ( Plasmodium falciparum) infectivity of host erythrocytes, ex vivo bacterial proliferation (of selected species) in presence of host plasma and intestinal inflammation assessed by fecal calprotectin. This study will test the hypotheses that the novel forms of iron, administered at equivalent doses to FeSO 4, will produce similar increases in iron status in iron-replete subjects, yet lower increases in ex vivo malaria infectivity, ex vivo bacterial proliferation, gut inflammation. Ultimately, this study seeks to contribute to development of safe and effective forms of supplemental iron to address the global burden of iron deficiency and anemia. Registration: ClinicalTrials.gov identifier: NCT03212677; registered: 11 July 2017.

Keywords: Iron supplementation; bacterial proliferation; ferrous sulfate; inflammation; iron-replete; malaria.

Conflict of interest statement

No competing interests were disclosed.

Copyright: © 2021 Lewis ED et al.

Figures

Figure 1.. Phase I CONSORT flow chart.
Figure 1.. Phase I CONSORT flow chart.
Figure 2.. Phase II CONSORT flow chart.
Figure 2.. Phase II CONSORT flow chart.

References

    1. Hurrell R, Egli I: Iron bioavailability and dietary reference values. Am J Clin Nutr. 2010;91(5):1461S–1467S. 10.3945/ajcn.2010.28674F
    1. Soofi S, Cousens S, Iqbal SP, et al. : Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet. 2013;382(9886):29–40. 10.1016/S0140-6736(13)60437-7
    1. Mayo-Wilson E, Imdad A, Junior J, et al. : Preventive zinc supplementation for children, and the effect of additional iron: a systematic review and meta-analysis. BMJ Open. 2014;4(6):e004647. 10.1136/bmjopen-2013-004647
    1. Zlotkin S, Newton S, Aimone AM, et al. : Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA. 2013;310(9):938–947. 10.1001/jama.2013.277129
    1. Jaeggi T, Kortman GA, Moretti D, et al. : Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731–742. 10.1136/gutjnl-2014-307720
    1. Zimmermann MB, Chassard C, Rohner F, et al. : The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr. 2010;92(6):1406–1415. 10.3945/ajcn.110.004564
    1. Sazawal S, Black RE, Ramsan M, et al. : Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006;367(9505):133–143. 10.1016/S0140-6736(06)67962-2
    1. Lynch S, Stoltzfus R, Rawat R: Critical review of strategies to prevent and control iron deficiency in children. Food Nutr Bull. 2007;28(4 Suppl):S610–620. 10.1177/15648265070284S413
    1. Kortman GA, Raffatellu M, Swinkels DW, et al. : Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev. 2014;38(6):1202–1234. 10.1111/1574-6976.12086
    1. Werner T, Wagner SJ, Martinez I, et al. : Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut. 2011;60(3):325–333. 10.1136/gut.2010.216929
    1. Dogan B, Suzuki H, Herlekar D, et al. : Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation. Inflamm Bowel Dis. 2014;20(11):1919–1932. 10.1097/MIB.0000000000000183
    1. Prentice AM, Doherty CP, Abrams SA, et al. : Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012;119(8):1922–1928. 10.1182/blood-2011-11-391219
    1. Hurrell R: Iron and malaria: absorption, efficacy and safety. Int J Vitam Nutr Res. 2010;80(4–5):279-92. 10.1024/0300-9831/a000035
    1. Hurrell RF: Safety and efficacy of iron supplements in malaria-endemic areas. Ann Nutr Metab. 2011;59(1):64–6. 10.1159/000332140
    1. Kartikasari AE, Georgiou NA, Visseren FL, et al. : Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J. 2006;20(2):353–5. 10.1096/fj.05-4700fje
    1. Aslam MF, Frazer DM, Faria N, et al. : Ferroportin mediates the intestinal absorption of iron from a nanoparticulate ferritin core mimetic in mice. FASEB J. 2014;28(8):3671–3678. 10.1096/fj.14-251520
    1. Latunde-Dada GO, Pereira DI, Tempest B, et al. : A nanoparticulate ferritin-core mimetic is well taken up by HuTu 80 duodenal cells and its absorption in mice is regulated by body iron. J Nutr. 2014;144(12):1896–1902. 10.3945/jn.114.201715
    1. Pereira DI, Aslam MF, Frazer DM, et al. : Dietary iron depletion at weaning imprints low microbiome diversity and this is not recovered with oral Nano Fe(III). MicrobiologyOpen. 2015;4(1):12–27. 10.1002/mbo3.213
    1. Pereira DI, Bruggraber SF, Faria N, et al. : Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans. Nanomedicine. 2014;10(8):1877–1886. 10.1016/j.nano.2014.06.012
    1. Bries AE, Wang C, Agbemafle I, et al. : Assessment of Acute Serum Iron, Non-Transferrin-Bound Iron, and Gastrointestinal Symptoms with 3-Week Consumption of Iron-Enriched Aspergillus oryzae Compared with Ferrous Sulfate. Curr Dev Nutr. 2019;3(12):nzz127. 10.1093/cdn/nzz127
    1. Matuszek G, Lewis E: Safe and effective delivery of supplemental iron to healthy volunteers.2019. 10.17605/
    1. Baldwin MR, Li X, Hanada T, et al. : Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells. Blood. 2015;125(17):2704–2711. 10.1182/blood-2014-11-611707
    1. Cross JH, Bradbury RS, Fulford AJ, et al. : Oral iron acutely elevates bacterial growth in human serum. Sci Rep. 2015;5:16670. 10.1038/srep16670
    1. Barnett JB, Dao MC, Hamer DH, et al. : Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2016;103(3):942–951. 10.3945/ajcn.115.115188
    1. Rozati M, Barnett J, Wu D, et al. : Cardio-metabolic and immunological impacts of extra virgin olive oil consumption in overweight and obese older adults: a randomized controlled trial. Nutr Metab (Lond). 2015;12:28. 10.1186/s12986-015-0022-5
    1. Dao MC, Sen S, Iyer C, et al. : Obesity during pregnancy and fetal iron status: is Hepcidin the link? J Perinatol. 2013;33(3):177–181. 10.1038/jp.2012.81
    1. Selhub J, Byun A, Liu Z, et al. : Dietary vitamin B 6 intake modulates colonic inflammation in the IL10 -/- model of inflammatory bowel disease. J Nutr Biochem. 2013;24(12):2138–2143. 10.1016/j.jnutbio.2013.08.005
    1. Saitoh O, Matsumoto H, Sugimori K, et al. : Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases. Digestion. 1995;56(1):67–75. 10.1159/000201224
    1. Moore T, Le A, Niemi AK, et al. : A new LC-MS/MS method for the clinical determination of reduced and oxidized glutathione from whole blood. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;929:51–55. 10.1016/j.jchromb.2013.04.004
    1. von Arnim U, Wex T, Ganzert C, et al. : Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome. Clin Exp Gastroenterol. 2016;9:97–103. 10.2147/CEG.S97701
    1. Tomcik K, Ibarra RA, Sadhukhan S, et al. : Isotopomer enrichment assay for very short chain fatty acids and its metabolic applications. Anal Biochem. 2011;410(1):110–117. 10.1016/j.ab.2010.11.030
    1. Caporaso JG, Kuczynski J, Stombaugh J, et al. : QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. 10.1038/nmeth.f.303
    1. Caporaso JG, Lauber CL, Walters WA, et al. : Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6(8):1621–1624. 10.1038/ismej.2012.8
    1. Pereira DI, Couto Irving SS, Lomer MC, et al. : A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. BMC Gastroenterol. 2014;14:103. 10.1186/1471-230X-14-103
    1. Poullis A, Foster R, Shetty A, et al. : Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13(2):279–284. 10.1158/1055-9965.EPI-03-0160
    1. Clark MA, Goheen MM, Fulford A, et al. : Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nat Commun. 2014;5:4446. 10.1038/ncomms5446
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, et al. : SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. 10.1136/bmj.e7586
    1. Low MS, Speedy J, Styles CE, et al. : Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev. 2016;4:CD009747. 10.1002/14651858.CD009747.pub2
    1. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization;2016.
    1. Trumbo P, Yates AA, Schlicker S, et al. : Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001;101(3):294–301. 10.1016/S0002-8223(01)00078-5
    1. Tolkien Z, Stecher L, Mander AP, et al. : Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383. 10.1371/journal.pone.0117383
    1. Haidar J, Omwega AM, Muroki NM, et al. : Daily versus weekly iron supplementation and prevention of iron deficiency anaemia in lactating women. East Afr Med J. 2003;80(1):11–16. 10.4314/eamj.v80i1.8661
    1. Bhatla N, Kaul N, Lal N, et al. : Comparison of effect of daily versus weekly iron supplementation during pregnancy on lipid peroxidation. J Obstet Gynaecol Res. 2009;35(3):438–445. 10.1111/j.1447-0756.2008.00972.x
    1. Bouzari Z, Basirat Z, Zeinal Zadeh M, et al. : Daily versus intermittent iron supplementation in pregnant women. BMC Res Notes. 2011;4:444. 10.1186/1756-0500-4-444
    1. Goonewardene IMR, Senadheera DI: Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy. J Obstet Gynaecol Res. 2018;44(3):417–424. 10.1111/jog.13546
    1. Siddiqui IA, Rahman MA, Jaleel A: Efficacy of daily vs. weekly supplementation of iron in schoolchildren with low iron status. J Trop Pediatr. 2004;50(5):276–278. 10.1093/tropej/50.5.276
    1. Zlotkin SH, Schauer C, Christofides A, et al. : Micronutrient sprinkles to control childhood anaemia. PLoS Med. 2005;2(1):e1. 10.1371/journal.pmed.0020001
    1. De-Regil LM, Jefferds ME, Sylvetsky AC, et al. : Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database Syst Rev. 2011; (12):CD009085. 10.1002/14651858.CD009085.pub2
    1. World Health Organization: WHO Guideline: Use of Multiple Micronutrient Powders for Point-of-Use Fortification of Foods Consumed by Infants and Young Children Aged 6–23 Months and Children Aged 2–12 Years.2016.
    1. Suchdev PS, Peña-Rosas JP, De-Regil LM: Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women. Cochrane Database Syst Rev. 2015; (6):CD011158. 10.1002/14651858.CD011158.pub2
    1. Use ICfHoTRfPfH: Choice of Control Group and Related Issues in Clinical Trials E10.2000.
    1. Wong D, Nielsen TB, Bonomo RA, et al. : Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev. 2017;30(1):409–447. 10.1128/CMR.00058-16
    1. Farver CF: Foundations in Diagnostic Pathology.2018.
    1. Jørgensen MG, Raaphorst RV, Veening JW: Noise and Stochasticity in Gene Expression: A Pathogenic Fate Determinant.2013;40:157–175. 10.1016/B978-0-12-417029-2.00006-6
    1. Taylor TA, Unakal CG: Staphylococcus Aureus. In StatPearls.Treasure Island (FL).2019.
    1. Poolman JT, Wacker M: Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field. J Infect Dis. 2016;213(1):6–13. 10.1093/infdis/jiv429
    1. : Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. The Lancet.2006;367(9505) : 10.1016/S0140-6736(06)67962-2 133-143 10.1016/S0140-6736(06)67962-2
    1. : Iron and malaria: absorption, efficacy and safety. Int J Vitam Nutr Res.2010;80(4-5) : 10.1024/0300-9831/a000035 279-92 10.1024/0300-9831/a000035
    1. : Safety and efficacy of iron supplements in malaria-endemic areas. Ann Nutr Metab.2011;59(1) : 10.1159/000332140 64-6 10.1159/000332140
    1. : Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J.2006;20(2) : 10.1096/fj.05-4700fje 353-5 10.1096/fj.05-4700fje
    1. : Non-typhi salmonella in children with severe malaria. East Afr Med J.2002;79(12) : 10.4314/eamj.v79i12.8670 633-9 10.4314/eamj.v79i12.8670
    1. : The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr.2010;92(6) : 10.3945/ajcn.110.004564 1406-15 10.3945/ajcn.110.004564

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner